View Archive »
Order a Reprint
About The Cover
The cover for issue 18 of Oncotarget features Figure 5, "Simvastatin prolonged survival, inhibited TGF-β signaling and prenylation, and induced apoptosis and autophagy in vivo," by Xiao, et al.
Table of Contents
Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies
Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies |
|
https://doi.org/10.18632/oncotarget.26718
Laura Hüser,
Peter Altevogt,
and Jochen Utikal
|
| 1662-1663 |
A blast from the past: ROS1 on the brain
A blast from the past: ROS1 on the brain |
|
https://doi.org/10.18632/oncotarget.26752
Igor Odintsov,
Romel Somwar,
and Monika A. Davare
|
| 1664-1666 |
Barriers to pre-treatment genomic characterization of the small renal mass
Barriers to pre-treatment genomic characterization of the small renal mass |
|
https://doi.org/10.18632/oncotarget.26756
Jamil S. Syed,
Cedric Lebacle,
and Brian Shuch
|
| 1667-1668 |
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors |
|
https://doi.org/10.18632/oncotarget.26707
Baptiste Louveau,
Julie Delyon,
Coralie Reger De Moura,
Maxime Battistella,
Fanelie Jouenne,
Lisa Golmard,
Aurelie Sadoux,
Marie-Pierre Podgorniak,
Ichrak Chami,
Oren Marco,
Julie Caramel,
Stephane Dalle,
Jean-Paul Feugeas,
Nicolas Dumaz,
Celeste Lebbe,
and Samia Mourah
|
| 1669-1687 |
Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry
Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry |
|
https://doi.org/10.18632/oncotarget.26706
Keita Tamura,
Makoto Horikawa,
Shumpei Sato,
Hideaki Miyake,
and Mitsutoshi Setou
|
| 1688-1703 |
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26722
Said Abdullah Khelwatty,
Sharadah Essapen,
Izhar Bagwan,
Margaret Green,
Alan M. Seddon,
and Helmout Modjtahedi
|
| 1704-1715 |
Statins affect human glioblastoma and other cancers through TGF-β inhibition
Statins affect human glioblastoma and other cancers through TGF-β inhibition |
|
https://doi.org/10.18632/oncotarget.26733
Aizhen Xiao,
Breanna Brenneman,
Desiree Floyd,
Laurey Comeau,
Kelsey Spurio,
Inan Olmez,
Jeongwu Lee,
Ichiro Nakano,
Jakub Godlewski,
Agnieszka Bronisz,
Noritaka Kagaya,
Kazuo Shin-ya,
and Benjamin Purow
|
| 1716-1728 |
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer |
|
https://doi.org/10.18632/oncotarget.26739
Till Eichenauer,
Mohammad Hussein,
Claudia Hube-Magg,
Martina Kluth,
Franziska Büscheck,
Doris Höflmayer,
Maria Christina Tsourlakis,
Stefan Steurer,
Till S. Clauditz,
Andreas M. Luebke,
Eike Burandt,
Waldemar Wilczak,
Andrea Hinsch,
David Dum,
Burkhard Beyer,
Thomas Steuber,
Hartwig Huland,
Markus Graefen,
Ronald Simon,
Guido Sauter,
Nathaniel Melling,
Thorsten Schlomm,
and Sarah Minner
|
| 1729-1744 |
Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma
Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma |
|
https://doi.org/10.18632/oncotarget.26741
Susanne Holck,
Louise Laurberg Klarskov,
and Lars-Inge Larsson
|
| 1745-1755 |
